Table 1.
Drug | IC50 | Mechanism of Action | Reference |
---|---|---|---|
Bortezomib | 17 nM | Proteolytic active site inhibitor | [6] |
CDDO | 13 μM | Allosteric ATPase inhibitor | [34] |
CDDO-Me | 1.9 μM | Allosteric ATPase inhibitor | [34] |
CDDO-Im | 2 μM | Allosteric ATPase inhibitor | [34] |
Compound 141 | 0.059 μM | Proteolytic active site inhibitor2 | [37] |
Coumarinic derivatives 4–8 | nd | Proteolytic active site inhibitor | [38] |
MG262 | 122 nM | Proteolytic active site inhibitor | [33] |
Obtusilactone A | 34.1 μM | Proteolytic active site inhibitor2 | [39] |
Sesamin | 19.9 μM | Proteolytic active site inhibitor2 | [39] |
Boronic acid-based non-peptide inhibitor
Suggested by computational modelling
nd – Not determined